Galera Therapeutics, Inc. (GRTX) Operating cash flow 2018–2025
Galera Therapeutics, Inc. (GRTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.0MFY2025 · since FY2018: -$22.2M → -$6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.0M | +50.2% |
| FY2024 | -$12.1M | +72.9% |
| FY2023 | -$44.8M | -3.3% |
| FY2022 | -$43.4M | +36.1% |
| FY2021 | -$68.0M | -14.1% |
| FY2020 | -$59.5M | -27.6% |
| FY2019 | -$46.7M | -110.5% |
| FY2018 | -$22.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice